My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

AbbVie (NY:ABBV)

227.45 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Dec 15, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9

...

90 91 Next >

2 Healthcare Stocks to Research Further and 1 Facing Challenges

October 03, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,...

Via StockStory

Topics Stocks

Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience

October 02, 2025

On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

These S&P500 stocks are gapping in today's session ↗

October 02, 2025

Stay tuned for the market movements in the S&P500 index on Thursday. Check out the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

A Closer Look at AbbVie's Options Market Dynamics ↗

September 30, 2025

Via Benzinga

Why AbbVie Stock Cruised to an Almost 6% Gain Today ↗

October 01, 2025

A new expansion project and a win for a peer pharmaceutical company were attracting investors to the shares.

Via The Motley Fool

Topics Government World Trade

Healthcare Sector Defies Headwinds, Rallies on Wall Street Amidst Shutdown and Jobs Data

October 01, 2025

New York, NY – October 1, 2025 – In a surprising turn of events on Wall Street today, the healthcare sector emerged as the undisputed leader, shrugging off the dual anxieties of a U.S. government...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Why AbbVie (ABBV) Stock Is Trading Up Today

October 01, 2025

Shares of pharmaceutical company AbbVie (NYSE:ABBV) jumped 5.2% in the afternoon session after the company submitted a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA)...

Via StockStory

Topics Government World Trade

10 Health Care Stocks Whale Activity In Today's Session ↗

October 01, 2025

Via Benzinga

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever ↗

October 01, 2025

If you are looking for dividend stocks that can provide a reliable, long-term income stream, consider buying AbbVie, Coca-Cola, and Chevron.

Via The Motley Fool

Topics Intellectual Property

U.S. Drug Pricing Reforms Send Ripples Across Global Healthcare Sector

September 30, 2025

The global healthcare sector is currently navigating a period of profound transformation, driven by aggressive regulatory changes emanating from the United States. As of late September 2025, a series...

Via MarketMinute

Topics Artificial Intelligence Economy World Trade

Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape

September 30, 2025

September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Healthcare Staffing Giant AMN Healthcare Soars Amidst Landmark Drug-Pricing Agreement

September 30, 2025

New York, NY – September 30, 2025 – AMN Healthcare Services (NYSE: AMN), a leading provider of healthcare staffing solutions, witnessed a significant upward movement in its stock today, reflecting a...

Via MarketMinute

Topics Government

Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge

September 30, 2025

Washington D.C. – September 30, 2025 – The pharmaceutical sector experienced a significant upward surge today, notably led by AbbVie (NYSE: ABBV), following reports of a groundbreaking drug-pricing...

Via MarketMinute

Topics Economy Government World Trade

AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know

September 30, 2025

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.

Via StockStory

Topics Government

Want Decades of Passive Income? Buy This Index Fund and Hold It Forever ↗

September 29, 2025

Dividend stocks can be a more predictable stream of income for investors.

Via The Motley Fool

Topics ETFs Stocks

Here's How Much $100 Invested In AbbVie 5 Years Ago Would Be Worth Today ↗

September 29, 2025

AbbVie (NYSE: ABBV) has outperformed the market over the past 5 years by 6.25% on an annualized basis producing an average annual return of 20.98%. Currently, AbbVie has a market capitalization of...

Via Benzinga

Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗

September 29, 2025

The U.S. pharmaceutical industry is at the center of a policy maelstrom.

Via Benzinga

Topics ETFs

1 Top ETF I Wouldn't Hesitate to Invest $1,000 Into Right Now ↗

September 29, 2025

This fund makes it easy to invest in the top dividend stocks.

Via The Motley Fool

Topics ETFs Stocks

Why the Schwab U.S. Dividend Equity ETF Could Be a Top Choice for Dividend Investors in 2025 ↗

September 28, 2025

Instead of choosing just one or two stocks, buy a bunch of quality dividend-payers with a single ETF.

Via The Motley Fool

Topics ETFs Stocks

5 Dividend Powerhouses to Buy and Never Sell ↗

September 28, 2025

These blue-chip giants have paid shareholders through wars, recessions, and pandemics.

Via The Motley Fool

Topics Intellectual Property

Major Insider Sale Casts Shadow on LENZ Therapeutics' Valuation

September 27, 2025

San Diego, CA – September 27, 2025 – LENZ Therapeutics (NASDAQ: LENZ) is facing heightened scrutiny this week following a significant insider share sale by a major shareholder, Versant Venture Capital...

Via MarketMinute

Topics Artificial Intelligence

NEXGEL Inc. Equity Warrants: A High-Stakes Bet on Future Profitability Amidst Rapid Growth

September 27, 2025

Langhorne, PA – September 27, 2025 – Investors in NEXGEL Inc. (NASDAQ: NXGL), a company at the forefront of hydrogel technology, are closely watching the trajectory of its equity warrants (NXGLW)....

Via MarketMinute

Topics Intellectual Property

Decoding AbbVie's Options Activity: What's the Big Picture? ↗

September 26, 2025

Investors with a lot of money to spend have taken a bearish stance on AbbVie (NYSE: ABBV). And retail traders should know. We noticed this today when the trades showed up on publicly available options...

Via Benzinga

Pharma Tariffs Back In Spotlight On New Trump Threat ↗

September 26, 2025

President Donald Trump threatened 100% tariffs on some drug imports.

Via Investor's Business Daily

Topics ETFs Government World Trade

Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet ↗

September 26, 2025

Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-de

Via Benzinga

Topics Government World Trade

3 Top Dividend Stocks to Buy and Hold Forever ↗

September 25, 2025

These blue chip dividend stocks offer both income and growth potential.

Via The Motley Fool

Topics Intellectual Property

Where Will AbbVie Be in 5 Years? ↗

September 25, 2025

This big pharmaceutical company should be significantly bigger five years from now.

Via The Motley Fool

Topics Earnings Economy Government

Novartis, AbbVie Face Legal Defeat Over 340B Contract Pharmacies ↗

September 24, 2025

A judge upholds Maine's contract pharmacy law, rejecting drugmakers' claims that it conflicts with federal rules governing the 340B drug discount program.

Via Benzinga

STRATA Skin Sciences Soars as Landmark Study Reveals Superior Vitiligo Treatment Efficacy

September 23, 2025

STRATA Skin Sciences Inc. (NASDAQ: SSKN) witnessed a dramatic surge in its stock price today, climbing 51.18% following the publication of a groundbreaking peer-reviewed study. The research highlights...

Via MarketMinute

Topics Intellectual Property

The Magnificent 7 Boom Just Triggered A Dot-Com Era Warning ↗

September 23, 2025

The Magnificent Seven tech giants are now worth $21 trillion—8x more than top health care stocks, echoing dot-com bubble extremes.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

90 91 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.